glp-1 agonist eli lilly FDA approves Foundayo, an oral alternative to Wegovy and Ozempic In the original clinical trials

In addition, according to observational and experimental data, DPP4 inhibitors [10, 11], sulfonylureas [11, 52], and insulin [53], are unlikely to slow cognitive decline beyond the benefits of glycemic control in diabetes without dementia

I dont want them to lose a whole bunch of weigh t, says Sue Pedersen, an endocrinologist and obesity medicine specialist at the C-endo diabetes and endocrinology clinic in Alberta

GLP-1 is a naturally occurring hormone produced in the gut and brain that regulates appetite, blood sugar, and satisfaction after eating

The participants then completed questionnaires related to drinking behaviors as described in the questionnaire section above